Allergan Inc: A 3 month, Multicenter,Double-masked,Randomized,Parallel,Vehicle-controlled Study of the Efficacy and Safety of 0.2 % Brimonidine-Purite Ophthalmic Solution for the Treatment of Acute Non-Arteritic Anterior Ishemic Optic......

Project: Research

Status	Finished
Effective start/end date	06/16/00 → 06/13/02

Project Details